Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with a few weeks of delay.
Buyer withdraws from acquiring Atrium's biosurgical business
April 24, 2019

Chinese HJ Capital 1, which is the parent company of SecQure Surgical Corporation, withdraws from purchasing Atrium's biosurgery operations due to missing authorizations. Atrium is a subsidiary of Swedish Getinge. The sales of the biosurgery business amounted to SEK 128m in 2017.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: